CODX vs CRM · rev $3.9M vs P/E 41, rev $41.52B
Co-Diagnostics, Inc. Common Stock (CODX) versus Salesforce.com Inc (CRM) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc Benioff.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CRM revenue for 2026-01-31 was $41.52B. Net income was $7.46B. Revenue was up 9.6% from 2025-01-31 to 2026-01-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
CODX currently screens at market cap $31.4M. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Not investment advice. Open the CODX and CRM stock pages for the full models.
Not investment advice.